{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Vancouver",
      "address_1": "14301 Se 1st St",
      "reason_for_recall": "Labeling:Label Mixup; IRBESARTAN, Tablet, 150 mg may be potentially mislabeled as    ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, NDC 00378041501, Pedigree: W003597, EXP: 6/24/2014;  CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD76686_7, EXP: 5/31/2014.",
      "address_2": "",
      "product_quantity": "60 Tablets",
      "code_info": "IRBESARTAN, Tablet, 150 mg has the following codes    Pedigree: W003649, EXP: 6/25/2014;  Pedigree: AD73686_7, EXP: 5/31/2014.",
      "center_classification_date": "20140116",
      "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.",
      "state": "WA",
      "product_description": "IRBESARTAN, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65862063830",
      "report_date": "20140122",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Aidapak Services, LLC",
      "recall_number": "D-717-2014",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "65707",
      "termination_date": "20140207",
      "more_code_info": "",
      "recall_initiation_date": "20130702",
      "postal_code": "98684-3501",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}